Original paper

Microfluidic DNA-based potassium nanosensors for improved dialysis treatment

Volume: 18, Issue: 1
Published: Jun 11, 2019
Abstract
Patients with end-stage renal disease (ESRD) have failed kidney function, and often must be treated with hemodialysis to extend the patient's life by artificially removing excess fluid and toxins from the blood. However, life-threatening treatment complications can occur because hemodialysis protocols are adjusted infrequently, as opposed to the kidneys which filter blood continuously. Infrequent blood tests, about once per month on average, are...
Paper Details
Title
Microfluidic DNA-based potassium nanosensors for improved dialysis treatment
Published Date
Jun 11, 2019
Volume
18
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.